Related Experiment Video
Updated: Jun 26, 2025
03:40
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
447
Therapeutic Management of Primary Atrophic Rhinitis (Ozene): About 4 Cases.
Firas Maalej1, Mohamed Amin Chaabouni1, Sirine Ayadi1
1Department of ENT, University Hospital Habib Bourguiba of Sfax, Faculty of Medicine of Sfax, University of Sfax, Sfax, Tunisia.
Ear, Nose, & Throat Journal
|May 14, 2024
Summary
This study on primary atrophic rhinitis found that Klebsiella ozaenae infection causes mucosal atrophy, crusts, and cacosmia. Treatment challenges remain due to the chronic nature of this nasal condition.
Area of Science:
- Otorhinolaryngology
- Infectious Diseases
Background:
- Primary atrophic rhinitis is a chronic nasal condition characterized by progressive mucosal atrophy.
- Klebsiella ozaenae is a potential causative agent, leading to specific clinical manifestations.
Purpose of the Study:
- To investigate the clinical features of primary atrophic rhinitis.
- To evaluate therapeutic strategies for this condition.
Main Methods:
- Retrospective analysis of 4 cases of atrophic rhinitis caused by Klebsiella ozaenae.
- Review of clinical presentation, including mucosal atrophy, crusting, and cacosmia.
- Assessment of medical (antibiotics: rifampicin, sulfamethoxazole, trimethoprim) and surgical (nasal cavity recalibration with silicone implants) treatments.
Main Results:
- All patients exhibited the classic triad: mucosal atrophy, crusts, and cacosmia.
- Medical treatment involved a 4-month course of antibiotics.
- Surgical intervention included nasal cavity recalibration.
- Three out of four patients experienced persistent nasal obstruction and cacosmia post-treatment.
Conclusions:
- Primary atrophic rhinitis presents significant therapeutic challenges due to its chronic nature.
- Effective treatment requires careful consideration of both medical and surgical options.
- Ongoing monitoring is essential for managing patients with atrophic rhinitis.
Related Concept Videos
01:16Drugs Used in Upper Respiratory Disorders: Overview
234
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
234
01:20Asthma: Pathogenesis and Management
389
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
389
01:17Drugs Used in Lower Respiratory Disorders: Overview
424
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
424
01:23Chronic Pharyngitis
1.9K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
1.9K
01:26COPD: Management Using Bronchodilators and Corticosteroids
197
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
197
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K